Lincoln Tsang, partner and head of European life sciences, will present at the Financial Times Global Pharmaceutical and Biotech Summit in London on November 9 on the panel “Harnessing the Clinical Value of Real-World Evidence.”
Monitoring and evaluating the safety and efficacy of drugs continues after they come to market, resulting in real-world evidence. Panelists will discuss topics including:
- What is involved in generating real-world evidence?
- How is technology transforming the way it is collected and used?
- How real-world evidence used in market access is evolving?
- What happens if a post-market trial undermines the results used to get drug approval?
- How can real-world evidence build trust in approved products as they become more established?
The summit is focused on the latest trends and innovations in life sciences. Industry leaders will discuss developments in areas such as drug discovery, clinical trials, market access and patient engagement.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.